This website is intended for healthcare professionals only. If you are not a healthcare professional, please
click here
Impacts
Assessment
Management
Rybrila
Contact
Adverse events should be reported to Clinigen at: E-mail:
drugsafety@clinigengroup.com
or Fax: +44(0)1932 824284
Prescribing Information